Michael P Cooreman
Company: Inventiva
Job title: Chief Medical Officer
Seminars:
Panel Discussion: Harmonizing Global Regulations to Drive Progress in Therapeutic Development 10:00 am
Considering market access in the context of distinct payer metrics and regulatory expectations From the FDA to the EMA: what are the differences? How to approach global regulatory agenciesRead more
day: Conference Day 2
Hepatic & Cardiometabolic Endpoints Demonstrate Efficacy of Lanifibranor Across the Spectrum of NASH Biology 9:00 am
Delving into the late-stage development of lanifibranor; a balanced α, β/δ and γ agonist, for the treatment of NASH Demonstrating efficacy on histological NASH resolution and improvement of fibrosis, cardiometabolic health, lipid and glucose metabolism, insulin resistance and systemic inflammation in the Phase 2b NATIVE study Correlating adiponectin, a downstream mediator of lanifibranor signaling with…Read more
day: Conference Day 2